International team develops potential COVID drug screening platform

An international research team comprised of researchers from Taiwan and Malaysia has developed a platform where drugs with the potential to inhibit infection by the virus that causes COVID-19 can be identified from massive data banks of known medicines in about 20 minutes.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)